Litcius/Paper detail

Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER

Anthony M. Joshua, Andrew J. Armstrong, Megan Crumbaker, Howard I. Scher, Johann S. de Bono, Bertrand Tombal, Maha Hussain, Cora N. Sternberg, Silke Gillessen, Joan Carles, Karim Fizazi, Ping Lin, William Duggan, Jennifer Sugg, David Russell, Tomasz M. Beer

2022European Journal of Cancer28 citationsDOIOpen Access PDF

Topics & Concepts

EnzalutamideProstate cancerMedicineMetforminStatinOncologyInternal medicineCancerAndrogen receptorInsulinCancer, Lipids, and MetabolismMetabolism, Diabetes, and CancerCancer, Stress, Anesthesia, and Immune Response
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER | Litcius